Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple antithrombotic therapy versus dual antiplatelet therapy for left ventricular thrombus after STEMI
NL-OMON43624Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2012
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of warfarin, aspirin and clopidogrel in Left ventricular thrombosis (LVT) and myocardial infarction (MI) (2 arms), sponsored by Amsterdam University Medical Center. Started Jan 2012; status: active, not recruiting.
02
Drugs
warfarinaspirinclopidogrel
03
Conditions
Left ventricular thrombosis (LVT)myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON43624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43624.